Interaction Between Renal Function and Microalbuminuria for Cardiovascular Risk in Hypertension The Nordic Diltiazem Study

被引:40
作者
Farbom, Patrik [1 ]
Wahlstrand, Bjorn [2 ]
Almgren, Peter [1 ]
Skrtic, Stanko [2 ]
Lanke, Jan [3 ]
Weiss, Lars [4 ]
Kjeldsen, Sverre [5 ]
Hedner, Thomas [2 ]
Melander, Olle [1 ]
机构
[1] Lund Univ, Dept Clin Sci, Malmo, Sweden
[2] Sahlgrens Acad, Dept Clin Pharmacol, Gothenburg, Sweden
[3] Lund Univ, Dept Stat, Lund, Sweden
[4] Karlstad Cent Hosp, Dept Nephrol, Karlstad, Sweden
[5] Univ Oslo, Ullevaal Univ Hosp, Oslo, Norway
基金
英国医学研究理事会;
关键词
hypertension; microalbuminuria; creatinine; glomerular filtration rate; interaction; cardiovascular risk;
D O I
10.1161/HYPERTENSIONAHA.107.109264
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
We investigated whether renal function and microalbuminuria are independent predictors and whether any interaction exists between them, regarding future cardiovascular disease in hypertensive patients (n=10 881) followed for 4.5 years. The primary end points (PEs) were fatal and nonfatal myocardial infarction and stroke and other cardiovascular deaths. Creatinine and glomerular filtration rate (GFR), estimated using the formulas of the Modification of Diet in Renal Disease study group and Cockroft and Gault and in a subsample (n=4929) of microalbuminuria and interaction terms of microalbuminuria and renal function, were related to the risk of the PE using Cox proportional hazards model after full adjustment. Increased creatinine (P < 0.001), decreased GFR from Cockroft and Gault (P=0.001), and decreased GFR from the Modification of Diet in Renal Disease study group (P=0.001) were all independent risk factors for the PE. Stepwise exclusion of patients with the poorest renal function excluded the possibility that the relationship between decreasing renal function and the PE was driven only by patients with severely impaired renal function. Microalbuminuria and all 3 of the indices of renal function predicted the PE independent of each other. There was a significant interaction between microalbuminuria and GFR from Cockroft and Gault (P=0.040) in prediction of the PE. Both renal function and microalbuminuria add independent prognostic information regarding cardiovascular risk in hypertensive patients. The cardiovascular risk associated with microalbuminuria increases with a decline in GFR, as demonstrated by a significant interaction between microalbuminuria and GFR from Cockroft and Gault. Because estimation of the total cardiovascular risk is essential for the aggressiveness of risk factor interventions, simultaneous inclusion of GFR and microalbuminuria in global cardiovascular risk assessment is essential. (Hypertension. 2008;52:115-122.)
引用
收藏
页码:115 / 122
页数:8
相关论文
共 24 条
  • [1] Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension
    Bigazzi, R
    Bianchi, S
    Baldari, D
    Campese, VM
    [J]. JOURNAL OF HYPERTENSION, 1998, 16 (09) : 1325 - 1333
  • [2] Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
    Brenner, BM
    Cooper, ME
    de Zeeuw, D
    Keane, WF
    Mitch, WE
    Parving, HH
    Remuzzi, G
    Snapinn, SM
    Zhang, ZX
    Shahinfar, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) : 861 - 869
  • [3] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    Chobanian, AV
    Bakris, GL
    Black, HR
    Cushman, WC
    Green, LA
    Izzo, JL
    Jones, DW
    Materson, BJ
    Oparil, S
    Wright, JT
    Roccella, EJ
    [J]. HYPERTENSION, 2003, 42 (06) : 1206 - 1252
  • [4] Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey
    Coresh, J
    Astor, BC
    Greene, T
    Eknoyan, G
    Levey, AS
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (01) : 1 - 12
  • [5] Prognostic significance of renal function in elderly patients with isolated Systolic hypertension:: Results from the Syst-eur trial
    De Leeuw, PW
    Thijs, L
    Birkenhäger, WH
    Voyaki, SM
    Efstratopoulos, AD
    Fagard, RH
    Leonetti, G
    Nachev, C
    Petrie, JC
    Rodicio, JL
    Rosenfeld, JJ
    Sarti, C
    Staessen, JA
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (09): : 2213 - 2222
  • [6] Renal dysfunction and ischemic heart disease mortality in a hypertensive population
    Hailpern, SM
    Cohen, HW
    Alderman, MH
    [J]. JOURNAL OF HYPERTENSION, 2005, 23 (10) : 1809 - 1816
  • [7] Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension:: the Nordic Diltiazem (NORDIL) study
    Hansson, L
    Hedner, T
    Lund-Johansen, P
    Kjeldsen, SE
    Lindholm, LH
    Syvertsen, JO
    Lanke, J
    de Faire, U
    Dahlöf, B
    Karlberg, BE
    [J]. LANCET, 2000, 356 (9227) : 359 - 365
  • [8] ISBEN H, 2006, DIABETES CARE, V29, P595
  • [9] A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation
    Levey, AS
    Bosch, JP
    Lewis, JB
    Greene, T
    Rogers, N
    Roth, D
    [J]. ANNALS OF INTERNAL MEDICINE, 1999, 130 (06) : 461 - +
  • [10] Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
    Lewis, EJ
    Hunsicker, LG
    Clarke, WR
    Berl, T
    Pohl, MA
    Lewis, JB
    Ritz, E
    Atkins, RC
    Rohde, R
    Raz, I
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) : 851 - 860